Mitoxantrone Suspended Phase 2 Trials for Leukemia, Lymphocytic / Leukemia Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
SuspendedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02462265Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients